Business Context and Reporting Period
Company: Oragenics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 3, 2007 (Event Date)
Reporting Period: Immediate notice of corporate governance event.
Context: The Company's common stock is quoted on the American Stock Exchange (AMEX) under the symbol "ONI". This filing addresses a failure to satisfy continued listing standards due to a change in Board composition.
Financial Metrics
This filing is a current report regarding corporate governance and listing status. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data.
Material Changes
- Board Composition Change: Independent director Mr. Hawes resigned from the Board of Directors.
- Listing Compliance Status: The Company is no longer in compliance with AMEX Guide Sections 802, 803, and 121B(2)(c), which require at least 50% of the Board to be independent directors and an Audit Committee of at least two independent directors.
- Regulatory Action: On May 3, 2007, the Company received a Warning Letter from the AMEX regarding this noncompliance.
Outlook, Risks, and Management Commentary
- Remediation Plan: The Company intends to begin a search for a new independent director to serve on the Board as soon as practicable.
- Compliance Deadline: The AMEX Warning Letter provides the Company until August 2, 2007, to regain compliance.
- Key Risk: There is no assurance the Company will locate and appoint a replacement independent director. Failure to regain compliance by the deadline will subject the Company to delisting proceedings.
Key Facts for Investor Verification
- Verify the current status of the search for a new independent director.
- Confirm whether the Company has appointed a replacement prior to the August 2, 2007 deadline.
- Monitor AMEX communications for any updates regarding delisting proceedings.
- Review the attached Press Release (Exhibit 99.1) for additional details on the resignation and search process.